Amanat Acquisition Corp Class A Ordinary Shares
AMAN
NASDAQ Global Market10.11
USD
+0.03
- -
CIK
0002112457
ISIN
KYG0375M1015
CUSIP
G0375M101
Return %
Stock
S&P500
1Y
1.00
15.98
3Y
1.00
62.25
5Y
1.00
67.55
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Pavan Cheruvu
- Sector
- Financial Services
- Industry
- Financial - Conglomerates
- Address
- 71 Fort Street, PO Box 500 George Town NJ United States of America KY1-1106
- IPO Date
- May 19, 2026
- CIK
- 0002112457
- Website
- amanatacquisition.com
- Similar Companies
- Business
- Amanat Acquisition Corp, a blank-check company focused on completing a merger, share exchange, asset acquisition, or similar business combination with a healthcare or healthcare-related business; headquartered in the United States and organized as a SPAC, the company aims to secure a controlled investment vehicle for a strategic healthcare target and to execute a transaction within a 24-month period. Main products and services - Primary business activity: formation and operation as a special purpose acquisition company (SPAC) intended to consummate a merger or other business combination with a target primarily in healthcare or healthcare-related industries; the SPAC structure itself is the core offering, enabling a subject company to access public markets through a pre-identified acquisition path. - Core investment and transaction services: capital deployment for a targeted healthcare business combination; facilitation of due diligence, regulatory filings, and merger integration planning; coordination with underwriters, legal counsel, auditors, and financial advisers for the de-SPAC process. - Public offering and listing services: structuring and marketing of the initial public offering (IPO) of Class A ordinary shares; managing trust account and proceeds for future acquisition purposes; arranging sponsor alignment and shareholder communication around the anticipated business combination. - Compliance, governance, and post-transaction support: maintaining fiduciary standards, investor disclosures, and governance structures; providing post-merger integration support and transition services for the combined entity, where applicable. Latest major company changes - Public listing plans and capital raise: files for a $75 million IPO for 7.5 million Class A ordinary shares, with proceeds intended to fund a future healthcare-focused business combination and maintain a trust balance for anticipated transactions; underwriters include Leerink Partners; preparation of SEC filings indicates active listing preparation on a U.S. exchange. - Regulatory and strategic positioning updates: communications indicate an intent to list on a major U.S. exchange under the ticker AMAN, with ongoing regulatory filings and readiness for a NASDAQ listing process; this reflects a significant strategic shift toward establishing a publicly traded vehicle for a healthcare-focused target. - Market and deal activity status: as of mid-2026, the company remains in the pre-IPO phase or early listing process, with a focus on finalizing transaction metrics, board and sponsor alignment, and securing regulatory approvals to advance a healthcare-focused business combination. Additional context - Industry and segments: healthcare and healthcare-related industries, including potential sub-sectors such as medical devices, healthcare services, biotechnology, digital health, or healthcare IT; the SPAC targets are typically established through strategic partnerships, alliances, and advisory networks within healthcare investment ecosystems. - Target markets/customers: institutional investors and public market participants seeking exposure to a healthcare-focused platform; eventual target entities would include hospital systems, clinics, pharmaceutical or diagnostics companies, medical technology firms, or healthcare service providers. - Geographic operations: U.S.-based vehicle with global or international transaction scope; operations centered in the United States, with potential cross-border deal opportunities given the global healthcare landscape. - Founding year and headquarters: incorporated as a SPAC for the purpose of completing a business combination; headquarters location stated in filings is within the United States, aligning with common SPAC practices for U.S. listings. - Subsidiaries/parent relationships: as a shell company, Amanat Acquisition Corp does not have operating subsidiaries prior to a business combination; post-transaction, the surviving company may inherit the target’s subsidiaries or form a newly consolidated corporate structure depending on the deal terms. Notes - Amanat Acquisition Corp is positioned as a healthcare-focused SPAC seeking to consummate a business combination with a healthcare or healthcare-related entity; the latest disclosed activity centers on IPO planning, SEC filings, and listing preparations under the AMAN ticker, with strategic emphasis on healthcare sector alignment. - For investors, key considerations include the timing of the IPO, the size and terms of the trust, potential deal timing within the 24-month horizon, and the identification of a qualified healthcare target that aligns with sponsor objectives and regulatory expectations.